Bowman and Brooke Logo

INSIGHTS

Bowman and Brooke lawyers speak regularly at legal education conferences and industry associations. They write for professional and industry publications, providing thought leadership on legal topics and industry trends.
June 14, 2017

"Lung Cancer: The Future of Asbestos Litigation?" By David Lutz and Whitney Cruz

Related Topics
news icon

"The next asbestos is asbestos." Minneapolis Partner David Lutz and Miami Partner Whitney Cruz discussed the future of asbestos litigation in an article published in DRI's For The Defense. Asbestos litigation is already a multi-billion dollar industry with mesothelioma diagnoses at its peak. While mesothelioma case filings are predicted to decline in the coming years, plaintiffs lawyers intend to transfer their focus on cases alleging lung cancer as a result of asbestos exposure. With roughly 200,000 lung cancer diagnoses per year in comparison to 3,000 - 3,500 annual mesothelioma diagnoses, the pool for potential plaintiffs' cases could be considerably larger. 

Highly experienced in handling asbestos litigation, David and Whitney provide their analysis of this predicted toxic tort trend along with sound advice on preparing to defend against this shift in litigation that replaces large sums of verdict and settlement dollars with a high volume of cases. 

Click the following link or the image below to download "Lung Cancer: The Future of Asbestos Litigation?"

The Future of Asbestos Litigation

Related: